X4 PHARMACEUTICALS, INC (XFOR) Net Margin
- 2026-06-30: Net Margin -183.48%.
- 2026-03-31: Net Margin -747.45%.
- 2025-12-31: Net Margin -931.66%.
- 2025-09-30: Net Margin -1689.24%.
Complete source-backed net margin history.
- Available history
- 2020-03-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -183.48% |
| 2026-03-31 | -747.45% |
| 2025-12-31 | -931.66% |
| 2025-09-30 | -1689.24% |
| 2025-06-30 | -1304.66% |
| 2025-03-31 | 0.98% |
| 2024-12-31 | -2776.92% |
| 2024-09-30 | -6552.86% |
| 2024-06-30 | 16133.75% |
| 2020-03-31 | -371.27% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -225.55% |
| 2024-12-31 | -1464.61% |
| 2020-12-31 | -2071.03% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |